Navigation Links
The Downside of Asthma Medication

Could a common class of drugs used for acute asthma attacks be causing the very thing it aims to treat?//

Perhaps, find researchers from Harvard School of Public Health and Brigham and Women’s Hospital who studied the use of bronchodilators known as beta-agonists in asthmatics.

Beta-agonists are the primary treatment used to relieve acute asthma attacks. The drugs come in many forms -- they may be delivered with an inhaler, given in pill or liquid form, delivered in a nebulizer, or given by injection. Whatever the mode of administration, they work by relaxing the airway and reducing airway responsiveness to allergens that cause it to restrict and cause an acute attack. Many people with asthma rely heavily on these medications, sometimes taking them several times a day. Previous research suggests regular use could increase sensitivity to airway constriction and thus lead to a greater number of attacks and more serious attacks, primarily by causing a desensitization of the beta2-adrenergic receptor (beta2AR) that the drug binds with to achieve its effects.

These researchers suggest an alternative mechanism. Their study finds the increased airway hyperresponsiveness seen in some regular users of beta-2 agonists may be due to increased expression of a substance called phospholipase C-beta (PLC-beta) in the smooth airway muscle that occurs with persistent high-level activation of the beta2AR. The finding may lead to new treatments for asthma targeting PLC-beta.

Writing in an accompanying commentary, other researchers from Harvard and Brigham and Women’s concur, noting, “Understanding the panoply of beta2AR-mediated events in airway smooth muscle might lead to the design of new agonists that avoid negative effects of beta2AR activation while enhancing events that lead to relaxation.”

'"/>




Page: 1

Related medicine news :

1. Downside of Diets in Children
2. New Drug for Bronchial Asthma
3. Asthma may actually be prevented by Dust and Dirt
4. Inhaled Steroids Safe & Effective for Children with Asthma
5. What happens when Asthmatics consume Aspirin?
6. Asthma! A new warning for heart disease
7. Asthma linked to obesity
8. Higher Risk of Asthma in children with autoimmune disease
9. Asthmatics at increased risk of lung cancer
10. Cleanliness might lead to Asthma
11. Asthma is not just a childhood condition
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... , ... March 29, 2017 , ... In the United ... 300,000 people each year develop other types of metastatic brain tumors(3). Though most meningiomas ... brain(3). As efforts focus on finding more effective treatment options, the San Diego ...
(Date:3/29/2017)... ... March 30, 2017 , ... Youth Futures International (YFI) premiered ... feedback from high school and college students who have participated in the program every ... and YFI is now accepting applications for enrollment. Visit http://www.ghana.yfiexperience.org to ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... or without a referral to new patients from Burnaby, BC. Patients in need ... full mouth reconstruction services, can see the esteemed team at Wall Centre Dental. ...
(Date:3/29/2017)... MINNETONKA, Minn. (PRWEB) , ... March 29, 2017 ... ... of medical office buildings (MOBs) and other outpatient facilities, and who are the ... look exclusively at those questions, Revista and Healthcare Real Estate Insights (HREI) found ...
(Date:3/29/2017)... Ca (PRWEB) , ... March 29, 2017 , ... ... process in many scientific laboratories. The assembly protocols involve many repetitive steps and ... suited for automation, which enables the high-throughput needed, and results in a lower ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... -- Stock-Callers.com navigates the Medical Instruments and Supplies ... of non-electronic medical, surgical, dental, and veterinary instruments and apparatus. ... Dickinson and Co. (NYSE: BDX), Antares Pharma Inc. (NASDAQ: ATRS), ... Download the free research reports on these stocks today: ... http://stock-callers.com/registration ...
(Date:3/30/2017)... 2017 The topical drug delivery market ... 2016, growing at a CAGR of 6.4% from 2016 to ... major end-user in market. While North America ... ... tables and 41 figures, 10 Company profiles spread across 144 ...
(Date:3/30/2017)... -- Lannett Company, Inc. (NYSE: LCI ) today ... payment against its existing revolving credit facility. ... million payment we made earlier this year in January, ... interest expense, at current rates" said Arthur Bedrosian ... solid and we continue to generate strong cash flows, ...
Breaking Medicine Technology: